Fast Five Quiz: Gastric Cancer Diagnosis

Daniel Catenacci, MD


August 24, 2022

According to the NCCN and European Society for Medical Oncology, DNA MMR testing to identify microsatellite instability using immunohistochemistry is recommended in all patients with newly diagnosed gastric cancer. MMR testing may help identify patients who may benefit from immunotherapy.

PD-L1 testing, HER2 testing, and liquid biopsies are used in patients with more advanced or metastatic gastric cancer.

Learn more about gastric cancer.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.